In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

A new study, published in the February issue of the urology journal BJU International, suggests that TEMPE, a topical anesthetic spray has the ... metered sprays of the local anaesthetic ...

In a 12 week, double-blind RCT, a metered-dose aerosol spray containing lidocaine and prilocaine (PSD502) showed a 6.3-fold increase in intravaginal ejaculatory latency times, improved all patient ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...